An update on the use of inhaled therapy in COPD

被引：3

作者：

Price, Oliver ^{[1
]}

Sarkar, Chandra ^{[2
]}

Konda, Shruthi ^{[1
]}

机构：

[1] Watford Dist Gen Hosp, Resp Med, Watford, England

[2] City & Hackney GP Confederat, London, England

来源：

CLINICAL MEDICINE | 2018年 / 18卷 / 05期

关键词：

COPD; inhaled corticosteroids; OBSTRUCTIVE PULMONARY-DISEASE; BLOOD EOSINOPHILS; EXACERBATIONS; WITHDRAWAL; CORTICOSTEROIDS; METAANALYSIS; TRIAL;

D O I：

10.7861/clinmedicine.18-5-387

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Inhaled corticosteroids represent the mainstay of pharmacological treatment for reversible airways disease, and traditionally have had widespread use in non-reversible chronic obstructive pulmonary disease (COPD). However, use in this group may expose patients to an increased risk of pneumonia, without significant benefit to symptoms or exacerbation frequency. Here we provide a guide to the use of inhaled therapy in COPD for the general physician.

引用

页码：387 / 390

页数：4

共 16 条

[1] Withdrawal of inhaled corticosteroids in COPD: A meta-analysis
Calzetta, Luigino
Matera, Maria Gabriella
Braido, Fulvio
Contoli, Marco
Corsico, Angelo
Di Marco, Fabiano
Santus, Pierachille
Scichilone, Nicola
Cazzola, Mario
Rogliani, Paola
[J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 : 148 - 158
[2] Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease
Kew, Kayleigh M.
Seniukovich, Alieksei
[J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (03):
[3] Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
Lipson, David A.
Barnhart, Frank
Brealey, Noushin
Brooks, Jean
Criner, Gerard J.
Day, Nicola C.
Dransfield, Mark T.
Halpin, David M. G.
Han, MeiLan K.
Jones, C. Elaine
Kilbride, Sally
Lange, Peter
Lomas, David A.
Martinez, Fernando J.
Singh, Dave
Tabberer, Maggie
Wise, Robert A.
Pascoe, Steven J.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (18) : 1671 - 1680
[4] Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD
Magnussen, Helgo
Disse, Bernd
Rodriguez-Roisin, Roberto
Kirsten, Anne
Watz, Henrik
Tetzlaff, Kay
Towse, Lesley
Finnigan, Helen
Dahl, Ronald
Decramer, Marc
Chanez, Pascal
Wouters, Emiel F. M.
Calverley, Peter M. A.
Chia, M.
Peters, M.
Polasek, J.
Sajkov, D.
Seale, P.
Wheatley, J.
Bedert, L.
Driesen, P.
Fievez, P.
Flemale, A.
Martinot, J-B
Mentens, Y.
Ninane, V
Peche, R.
Plas, B.
van Zandweghe, L.
Adalberto, R.
Carmo Moreira, M. A.
Fritscher, C.
Gondim, H.
Jardim, J. R. B.
Dancheva, A.
Kostov, K.
Lllieva-Fartunova, V
Metev, H.
Osmanliev, D.
Palaveev, Rashkov K.
Taseva, M.
Troshanova, E.
Bai, C.
Baiqiang, C.
Li, H.
Lin, Y.
Tang, Y.
Wu, Y.
Xin, J.
Yao, W.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (14) : 1285 - 1294
[5] A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease
Miravitlles, Marc
Cosio, Borja G.
Arnedillo, Aurelio
Calle, Myriam
Alcazar-Navarrete, Bernardino
Gonzalez, Cruz
Esteban, Cristobal
Antonio Trigueros, Juan
Rodriguez Gonzalez-Moro, Jose Miguel
Quintano Jimenez, Jose Antonio
Baloira, Adolfo
[J]. RESPIRATORY RESEARCH, 2017, 18
[6] Withdrawal of inhaled corticosteroids in individuals with COPD - a systematic review and comment on trial methodology
Nadeem, Nighat J.
Taylor, Stephanie J. C.
Eldridge, Sandra M.
[J]. RESPIRATORY RESEARCH, 2011, 12
[7] NICE, 2019, Chronic obstructive pulmonary disease in over 16s: diagnosis and management
[8] Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials
Pascoe, Steven
Locantore, Nicholas
Dransfield, Mark T.
Barnes, Neil C.
Pavord, Ian D.
[J]. LANCET RESPIRATORY MEDICINE, 2015, 3 (06) : 435 - 442
[9] Blood Eosinophils and Response to Maintenance Chronic Obstructive Pulmonary Disease Treatment Data from the FLAME Trial
Roche, Nicolas
Chapman, Kenneth R.
Vogelmeier, Claus F.
Herth, Felix J. F.
Thach, Chau
Fogel, Robert
Olsson, Petter
Patalano, Francesco
Banerji, Donald
Wedzicha, Jadwiga A.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195 (09) : 1189 - 1197
[10] LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis
Rodrigo, Gustavo J.
Price, David
Anzueto, Antonio
Singh, Dave
Altman, Pablo
Bader, Giovanni
Patalano, Francesco
Fogel, Robert
Kostikas, Konstantinos
[J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 907 - 922

← 1 2 →